MiMedx: Q2 Earnings Snapshot

August 2, 2022 GMT

MARIETTA, Ga. (AP) _ MiMedx Group Inc. (MDXG) on Tuesday reported a loss of $12.5 million in its second quarter.

The Marietta, Georgia-based company said it had a loss of 11 cents per share.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 6 cents per share.

The developer of biomaterials made from sterilized human amniotic membrane posted revenue of $66.9 million in the period, exceeding Street forecasts. Three analysts surveyed by Zacks expected $65.1 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MDXG at https://www.zacks.com/ap/MDXG